| CTRI Number |
CTRI/2023/01/049241 [Registered on: 25/01/2023] Trial Registered Prospectively |
| Last Modified On: |
09/01/2023 |
| Post Graduate Thesis |
No |
| Type of Trial |
Observational |
|
Type of Study
|
Cross Sectional Study |
| Study Design |
Other |
|
Public Title of Study
|
INFLUENCE OF YOGA ON IMMUNITY AND COGNITION IN LONG-TERM YOGA PRACTITIONERS AND NON-YOGA PRACTITIONERS |
|
Scientific Title of Study
|
INFLUENCE OF YOGA ON MARKERS OF IMMUNOSENESCENCE, INFLAMMATION AND COGNITION IN LONG-TERM YOGA PRACTITIONERS AND YOGA NAÃVE INDIVIDUALS – A STRATIFIED, CROSS-SECTIONAL STUDY |
| Trial Acronym |
|
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Manjunath NK |
| Designation |
Director of Research, Dept. of Life Sciences |
| Affiliation |
SVYASA |
| Address |
Anveshana Research Laboratory Kalluballu Post, Anekal, Swami Vivekananda Rd, Jigani, Karnataka Bangalore KARNATAKA 560105 India |
| Phone |
|
| Fax |
|
| Email |
nkmsharma@svyasa.org |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Vijaya Majumdar |
| Designation |
Associate Professor, Dept. of Life Sciencces |
| Affiliation |
Swami Vivekananda Yoga Anusandhana Samsthana (SVYASA) |
| Address |
Anveshana Research Laboratory, 1st floor Kalluballu Post, Anekal, Swami Vivekananda Rd, Jigani, Karnataka Bangalore KARNATAKA 560105 India |
| Phone |
9036800821 |
| Fax |
|
| Email |
vijaya.majumdar@svyasa.edu.in |
|
Details of Contact Person Public Query
|
| Name |
Dr Vijaya Majumdar |
| Designation |
Associate Professor, Dept. of Life Sciencces |
| Affiliation |
Swami Vivekananda Yoga Anusandhana Samsthana (SVYASA) |
| Address |
Anveshana Research Laboratory,
1st floor Kalluballu Post, Anekal, Swami Vivekananda Rd, Jigani, Karnataka Bangalore KARNATAKA 560105 India |
| Phone |
9036800821 |
| Fax |
|
| Email |
vijaya.majumdar@svyasa.edu.in |
|
|
Source of Monetary or Material Support
|
| Dr. N K Manjunath, Director of Research, Swami Vivekananda Yoga Anusandhana Samsthana (SVYASA) Kalluballu Post, Anekal, Swami Vivekananda Rd, Jigani, Karnataka |
|
|
Primary Sponsor
|
| Name |
Swami Vivekananda Yoga Anusandhana Samsthana |
| Address |
Kalluballu Post, Anekal, Swami Vivekananda Rd, Jigani, Karnataka |
| Type of Sponsor |
Research institution and hospital |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Vijaya Majumdar |
Swami Vivekananda Yoga Anusandhana Samsthana (SVYASA) |
Anveshana Research Laboratory
1st floor Bangalore KARNATAKA |
9036800821
vijaya.majumdar@svyasa.edu.in |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| SVYASA |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Healthy Human Volunteers |
Long-term yoga practitioners and Yoga naive participants |
|
|
Intervention / Comparator Agent
|
|
|
Inclusion Criteria
|
| Age From |
20.00 Year(s) |
| Age To |
80.00 Year(s) |
| Gender |
Both |
| Details |
Long-term practitioners minimum 3 years and maximum 10 years of practice. Yoga session includes asana, pranayama, meditation
Yoga naive practitioners who are age matched and who are physically active
|
|
| ExclusionCriteria |
| Details |
Those who have undergone recent surgery, acute infection, fever, or any allergy during the past 3 months. Participants with uncontrolled diabetes and hypertension and psychological disorders will be excluded from the study. |
|
|
Method of Generating Random Sequence
|
Stratified randomization |
|
Method of Concealment
|
Sequentially numbered, sealed, opaque envelopes |
|
Blinding/Masking
|
Not Applicable |
|
Primary Outcome
|
| Outcome |
TimePoints |
| Status of immunosenescence markers and inflammatory markers |
one time point |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| Cognition markers |
one time point |
|
|
Target Sample Size
|
Total Sample Size="300" Sample Size from India="300"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
01/07/2023 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="6" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Yet Recruiting |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
none yet |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - YES
- What data in particular will be shared?
Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).
- What additional supporting information will be shared?
Response - Study Protocol Response - Statistical Analysis Plan Response - Informed Consent Form
- Who will be able to view these files?
Response - Researchers whose proposed use of the data has been approved by an independent review committee identified for this purpose.
- For what types of analyses will this data be available?
Response - To achieve aims in the approved proposal.
- By what mechanism will data be made available?
Response - Proposals should be directed to [vijaya.majumdar@svyasa.edu.in].
- For how long will this data be available start date provided 01-12-2023 and end date provided 01-12-2028?
Response - Immediately following publication. No end date.
- Any URL or additional information regarding plan/policy for sharing IPD?
Additional Information - NIL
|
|
Brief Summary
|
Aging leads to undesirable changes in physical and psychological health associated with aging. Yoga is a holistic practice which is shown to successfully modulate the mind and thus effective in curbing these changes. There is evidence to suggest that mind-body therapies greatly help in combating the downfall of immune system, prevent cognitive decline and reduce inflammaging. Yoga not only help prevent but also reverse these changes paving the way for a better future in elderly care. |